Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Puts Lab-Developed Test Oversight Plans On Hold

Nov 18 2016

• By Ferdous Al-Faruque

PCR strip test tubes and micropipette in genetics laboratory. Toned photo

Related Content

MDUFA IV Takes Shape: A Catalogue Of Draft Commitments

Aug 29 2016

Don't Finalize LDT Guidance, House Appropriators Tell FDA

Apr 20 2016

FDA Releases LDT Regulatory Framework, Notification Draft Guidances

Oct 06 2014

Lab Group Urges FDA To Wait For Congress On LDT Issue

Apr 07 2016

Shuren In The Lion’s Den: Device Center Chief Defends LDT Plan At Clinical Lab Meeting, Fields Wide Array Of Questions

Mar 14 2016

Sen. Alexander Wants To ‘Start From Scratch’ In Regulating Lab-Developed Tests

Sep 21 2016

Additional Topics

United States FDA Diagnostics Medical Device In Vitro Diagnostics

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window